Dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years).
solubility
Soluble in DMSO
pka
8.23±0.40(Predicted)
form
solid
Usage And Synthesis
Description
RET-IN-1 is an oral and selective investigational drug in clinical development for the treatment of patients with cancers that harbor abnormalities in the rearranged during transfection (RET) kinase.
